Latest News for: mfn
Edit
White House announces MFN agreement with drug manufacturer Regeneron (AHA - American Hospital Association)
Public Technologies 24 Apr 2026
) The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent ... patients at no cost. [...] ... Attachments Original document Permalink.
Edit
MFN price controls would drain pensions and put retirements at risk (PhRMA - Pharmaceutical Research and Manufacturers of America)
Public Technologies 23 Apr 2026
) A new analysis by NDP Analytics shows that harmful policies like Most Favored Nation price controls threaten far more than patient access and biopharmaceutical innovation ... The big picture ... [...] ... Disclaimer.
Edit
CMS undermines medical progress with MFN price controls (PhRMA - Pharmaceutical Research and Manufacturers of America)
Public Technologies 16 Apr 2026
Edit
Dem Health Leaders Letter to Abbvie re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Sanofi re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Amgen re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply? ... the specific formula(s) used to determine the Medicaid MFN pricing.
Edit
Dem Health Leaders Letter to Merck re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Genentech re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Boehringer re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to GSK re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Bristol MS re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Novartis re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to J and J re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Dem Health Leaders Letter to Gilead re MFN (US House of Representatives Committee on Education and Labor)
Public Technologies 14 Apr 2026
Will most-favored nation (MFN) prices apply to newly launched drugs across all markets in the United States? If not, to which markets/payers does this agreement apply?.
Edit
Impact of U.S. Administration Pharmaceutical Policies: MFN Pricing and Tariff Exemptions Reshaping Global Drug Pricing and Supply Chains
Pharmiweb 10 Apr 2026
Its two central pillars—the Most Favored Nation (MFN) pricing mechanism and tariff adjustments on patented drugs—aim to reduce drug prices in the United States, decrease external dependence, and strengthen domestic supply chains.
- 1
- 2
- Next page »